
Sign up to save your podcasts
Or


Episode 19 is the first of two episodes that will discuss a topic near and dear to us here at NETRF: NET research. Advancing NET research is the core of our mission, and it’s a crucial need, because NETs are extremely complicated cancers and there is still a lot the medical community needs to learn about them.
How do scientists do research, from beginning to end? And what are some of the challenges that specifically face NET researchers as they work through that process? Learn why basic research in the laboratory is crucial to discovering new treatments. Clinical trials are just the last stage of this process, and they cannot happen without years of careful pre-clinical work, which is often underappreciated and underfunded.
After you’ve listened to the episode, test your NET Knowledge by taking the LACNETS quiz here.
John Kanki, PhD
Director of Research
NETRF
Dawn Quelle, PhD
Professor of Pharmacology and Neurology
Holden Comprehensive Cancer Center University of Iowa, College of Medicine
Co-Chair of NETRF Board of Scientific Advisors
Ramesh Shivdasani, MD, PhD
Oncologist,
Dana-Farber Cancer Institute
Professor,
Harvard Medical School
NETRF Board of Scientific Advisors
Chrissie Thirlwell, MD, PhD
Mireille Gillings Professor of Cancer Genomics
University of Exeter
Co-Chair of NETRF Board of Scientific Advisors
Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
NETWise Episode 31: 2023 Year in Review
NETRF 2023 Research Symposium: Personalized Medicine
NETRF 2023 Research Symposium: Improving Radiotheranostics
NETRF 2023 Research Symposium: NET Pathways & Targets
NETRF 2023 Research Symposium: Tumor Evolution & Microenvironment
NETRF 2024 Know Your NETs Virtual Conference: Combining & Sequencing Novel
NETRF 2024 Providence Conference: Basic and Translational Research
NETRF 2024 Providence Conference: NET Clinical Trials
NETRF 2024 Know Your NETs Virtual Conference: Welcome & Discovery in NETs w/ Basic
Celebrating Milestones in Neuroendocrine Tumor Research (2023)
NETRF Awards Eleven Research Grants to Study Neuroendocrine Cancer
NETRF Research Highlights 2023: Drug-tolerant persister cells in relapsed high-grade neuroendocrine carcinoma, by Carl Gay, MD, PhD
NETRF Research Highlights 2023: NET-SMART therapy, a targeted prodrug strategy, by Justin Annes, MD, PhD
NETRF Research Highlights 2023: Imaging and endo radiotherapy of NETs by endocytic modulation of somatostatin receptors, by Patricia Pereira, PhD
NETRF Research Highlights 2023: Targeting serotonin metabolism in small bowel NETs, by Po Hien Ear, PhD
NETRF Research Highlights 2023: Novel PDXovo models for neuroendocrine neoplasms, by Iacovos Michael, PhD
Advancing Neuroendocrine Tumor Research Through a New Clinically Relevant Mouse Model
The post NETWise Episode 19: NET Research—Part One appeared first on NETRF.
While most neuroendocrine tumors are low-grade and slow growing, there are some that are high-grade and very aggressive. These high-grade NETs are treated very differently. In the newest episode of NETWise, we turn the spotlight on high-grade NETs, talk with NET physicians about the treatment challenges, and hear from a patient and caregiver about dealing with the diagnosis. Listen above.
Net experts featured in this podcast:
The post NETWise Episode 18: High-Grade NETs and NECs appeared first on NETRF.
The liver is very often the first and most significant site of neuroendocrine tumor metastasis and for many people, managing the disease in the liver is the most challenging part of their NET journey. In this episode of NETWise, we’re going to focus on an organ that is almost never a NET primary site, but nevertheless is crucially important to many people with NETs: the liver.
First, you’ll learn that the liver is a unique organ with a resiliency that is remarkable. Why is the liver such a frequent site for NET metastases? Hear about the various treatments for liver neuroendocrine tumors and the risks and benefits of each of them.
Cindy Lovelace and Katherine Mueller share their experiences, the treatments they have had for their liver NETs, and their advice for other patients.
Dr. Mary Maluccio
Surgical Oncologist
Medical Director
Louisiana State University/Ochsner Medical Center NET Program
Dr. Satya Das
Medical Oncologist
Co-Director, Neuroendocrine Tumor Program
Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center
Dr. Helen Te
Clinical Hepatologist
University of Chicago Medical Center
Dr. Xavier Keutgen
Director of the Neuroendocrine Tumor Center
University of Chicago Medical Center
Dr. Osman Ahmed
Interventional Radiologist
University of Chicago Medical Center
Special thanks to Cindy Lovelace and Katherine Mueller for sharing their stories. This episode is dedicated to Katherine’s memory. We thank her family for their support of her inclusion in this podcast.
2021 KNOW YOUR NETS: Keeping your Liver Healthy
2020 KNOW YOUR NETS: How Much Can Liver Take – Treating with IR
2020 KNOW YOUR NETS: NETs Surgery: Risks and Benefits for Metastatic Tumors
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
The post NETWise Episode 17: Focus on Liver NETs appeared first on NETRF.
They say “you are what you eat”, and that can be a real challenge for people with neuroendocrine tumors. In this episode of NETWise, we’re going to look at all the ways that NETs interact with nutrition–how having a NET can affect your body’s ability to use nutrients properly, and how what you choose to eat can help or hurt your NET treatment and quality of life.
Learn about how neuroendocrine tumors can complicate digestion and how to identify food triggers that may cause symptoms. You’ll hear about enzymes and supplements, and why what may be a healthy diet for some people may not be the best for people with NETs.
You’ll hear from Devon Billings and Cindy Abel who share their stories and what they have learned about enjoying food and managing their nutrition.
Dr. Michelle Kang-Kim,
Gastroenterologist
Co-Director of the Center for Carcinoid and Neuroendocrine
Tumors
Mt. Sinai Medical Center, New York
Leigh Anne Burns, MD, RD, LDN
Registered Dietician
Greta Macaire
Oncology Dietician/Nutritionist
University of California, San Francisco
Special thanks to Devon Billings and Cindy Abel who shared their personal stories for this episode.
Eating Right with NETs
Nutrition and Neuroendocrine Tumors with Greta Macaire
NETs Nutrition with Luz Chavez
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
The post NETWise Episode 16: NETs and Nutrition appeared first on NETRF.
When you’re fighting cancer, treating your tumors is only part of the care you need to continue living your best life. Caring for you as a person – mind, body, and spirit – is the focus of a dedicated team of interdisciplinary professionals who have a lot to offer people with neuroendocrine tumors. Just don’t be scared of the “P” word!
Palliative care addresses all the issues impacting a person’s quality of life. These might include managing symptoms and side effects, managing pain, and dealing with the psychological and emotional ramifications of living with a serious illness. A landmark study done at Harvard in 2010 demonstrated that cancer patients receiving dedicated palliative care on top of treatment for their cancer did better in a myriad of ways.
In this episode, hear from physicians about what palliative care is—and is not. Richard Redding and Laurel Howard share their stories about how palliative care has helped them deal with their illness. Caregiver Roseanne Crane talks about her husband’s experience with a palliative care team.
Dr. Steve Pantilat
Palliative Care
The University of California, San Francisco
Dr. Sandy Tun
Pallaitive Care
The University of Chicago
Abraham Labrada-Santiago
Chaplain
Mayo Clinic
Share Your Story
Causes of Neuroendocrine Tumors
The Emotions of Living with Neuroendocrine Tumors
Assistance and Support for Neuroendocrine Tumors
Living Well with Serious Illness
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
The post NETWise Episode 15: Supportive Care for the Mind, Body, and Soul appeared first on NETRF.
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors that occur inside or outside the adrenal glands. Affecting approximately 1 in 3,000 people, pheochromocytomas and paragangliomas are unique tumors in that they can produce excessive amounts of “fight or flight” hormones that can cause over 100 different signs and symptoms. The symptoms can come and go and without warning but if left untreated can cause life-threatening damage.
In this episode of NETWise, we will explain what these tumors are and how they are different from other NETs, the genetic aspects of these tumors; why it’s so important for pheochromocytoma and paraganglioma patients to be managed by a team of doctors who specialize in these tumors, surgical options; drug therapies and new nuclear medicine treatments that are offering hope to patients.
On average, it takes three years from the time a patient begins experiencing symptoms before a correct diagnosis is reached. You’ll have a chance to hear Eli Soto’s story. He was diagnosed in 2018 but doctors estimate the pheo was slowing growing inside him for more than a decade. Eli shares his incredible journey and the lessons he learned that could help other patients.
Bonnie Bennett
Nurse Coordinator for the Neuroendocrine Tumor program
University of Pennsylvania
Dr. Lauren Fishbein
Endocrinologist
UCHealth and the University of Colorado School of Medicine
Samantha Greenberg
Genetic Counselor and Paraganglioma Clinic Manager
Huntsman Cancer Institute
Dr. Joseph Dillon
Endocrinologist
University of Iowa
Dr. Erik Mittra
Chief of Nuclear Medicine and Molecular Imaging
Oregon Health and Science University
Dr. Nancy Perrier
Head of Surgical Endocrinology
MD Anderson Cancer Center
Dr. Nancy Sharma
Medical Oncologist
Swedish Cancer Institute
Check out where pheochromocytomas and paragangliomas, both very rare NETs, can occur in the body.
Share Your Story
PheoPara Alliance
Causes of Neuroendocrine Tumors
Genetic Testing for NETs
Pheochromocytoma and Paraganglioma
Pheo Para Center of Excellence Program
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
The post NETWise Episode 14: Pheos and Paras — NETs Known as “the Great Mimic” appeared first on NETRF.
What role do genetics play in neuroendocrine tumors (NETs)? Is genetic screening right for you? Should you have your family members screened for a hereditary gene? In this episode of NETWise, we will explore the relationship between NETs and DNA and explain why your genetic code might hold important implications for treatment strategies, prognosis, and the health of family members.
You’ll hear from Gretchen Thone, a genetic counselor at Geisinger Medical Center about how hereditary conditions can be passed from parents to children and the importance of seeking professional testing and counseling. Dr. Joseph Dillon from the University of Iowa, Dr. Lauren Fishbein from the University of Colorado and Dr. Mark Lewis from Intermountain Healthcare in Utah will share their expertise about the genes that are linked to syndromes that have an increased risk of developing NETs.
You will also have an opportunity to hear from John Metzcar, a patient with Multiple Endocrine Neoplasia, Type I or “MEN-1” and Doug Karle, a patient with Von Hippel Lindau Syndrome. They will share their personal stories of living with a hereditary syndrome, the role genetic testing played in their journey and how being a father shaped their experiences and decisions with genetic testing.
While most NETs are not caused by genetic mutations, here are some syndromes that are related to neuroendocrine tumors.
Share Your Story
Causes of NETs
Genetic Testing for NETs
Pheochromocytoma and Paraganglioma
Von Hippel Lindau Alliance
PheoPara Alliance
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
The post NETWise Episode 13: NETs and Genetic Screening appeared first on NETRF.
A diagnosis of neuroendocrine cancer impacts the person who receives the diagnosis, as well as those they love. A spouse, child, or friend may take on the role of caregiver—a partner to the patient on the NET journey and advocate for their loved one. It’s a job they did not anticipate or prepare for. This episode of NETWise focuses on caregivers to recognize and celebrate their essential place in the care team. Hear their unique perspectives and what their support means to a patient.
We invite you to express your love and gratitude to those in your family or community who care for you through a Love Note gift. Leave a message about why they mean the world to you and NETRF will send your message along with a Love Note to the person who has been by your side every step of the way. This is a beautiful way to donate to NET research; while recognizing those who give you a sense of hope.
Special thanks to Chuck Murphy, Katie Bourke, Tim Cape and Harold Bouis for sharing their stories. This episode is dedicated in honor of Harold.
Share Your Story
The Emotions of Living with Neuroendocrine Tumors
Assistance and Support for Neuroendocrine Tumors
Living Well with Serious Illness
LACNETS Caregiver Support Group
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
The post NETWise Episode 12: The Importance of Caregivers appeared first on NETRF.
Facing a diagnosis of neuroendocrine cancer, when you are a teenager or young adult, presents unique medical, social, financial, and even fertility challenges. How do you navigate the healthcare system? Who do you tell about your illness and when? Will you be able to have a career? Can you have children?
In this episode, hear from NET experts Dr. Jaydira Del Rivero and Dr. Manisha Shah about the diagnosis of NETs and prognosis in young people. Kalen Fletcher, a Licensed Independent Clinical Social Worker, talks about young people’s emotional reactions to living with cancer. Dr. Mark Lewis, a patient and physician, shares his story. We also hear from Sophia Hurtado and her mother Maryanne about Sophia’s courage.
The world of “AYA” patients—adolescents and young adults—does not have to be isolating. There is hope and support if you know where to look.
Causes of Neuroendocrine Tumors
The Emotions of Living with Neuroendocrine Tumors
stupidcancer.org
thesamfund.org
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
The post NETWise Episode 11: AYA (Adolescents and Young Adults) and NETs appeared first on NETRF.
While there are more options, treatment for PNETs needs to be individualized since these tumors can vary significantly in stage, grade, and their ability to cause hormonal symptoms. PNETs are complex because the pancreas plays an essential role in our bodies’ functions. If you or someone you know has a PNET, this episode of NETWise discusses the importance of the pancreas and how PNETs are diagnosed. You’ll also learn that there are several genetic syndromes that can increase vulnerability to PNETs.
Hear about treatment options and research for PNETs from NET specialists Drs. Emily Bergsland and Phillip Phillip.
Pancreatic Surgeries: The pancreas is surrounded by important organs and made up of different parts. Take a look at these illustrations to improve your understanding of pancreas anatomy and the different surgeries used to treat it.
PNETs
Treatment Options
VIDEO: Pancreas NET Breakout—Dr. Pam Kunz
VIDEO: Surgery for NETs—Dr. James Howe
VIDEO: Functional vs. nonfunctional tumors—Dr. Heloisa Soares
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:Request a Mailed Copy of our Neuroendocrine Cancer Guide
Information and Resources for the Newly Diagnosed
NETRF YouTube Channel
The post NETWise Episode 10: Pancreatic NETs appeared first on NETRF.
From the publisher's feed

43,359 Listeners

56,447 Listeners

59 Listeners

15,702 Listeners

2 Listeners

749 Listeners

3 Listeners